SCHEMBL1102741

SCHEMBL1102741

c1ccc2c(c1)N(c1c3ccccc3c(N3c4ccccc4[Si]4(CCCC4)c4ccccc43)c3cnccc13)c1ccccc1[Si]21CCCC1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.32
MAOB P27338 5/20 0.32
IDO1 P14902 2/20 0.32
ACHE P22303 2/20 0.32
KDM4E B2RXH2 1/20 0.32
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
IKBKB O14920 1/20 0.32
AURKA O14965 1/20 0.32
CHUK O15111 1/20 0.32
ALDH1A1 P00352 1/20 0.32
PIM1 P11309 1/20 0.32
TOP1 P11387 1/20 0.32
GABRA1 P14867 1/20 0.32
HPGD P15428 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16314377 0.84 MPO (0.31) MAOAMAOBIDO1ACHEKDM4E
SCHEMBL1102739 0.82 MAOA (0.33) MAOAMAOBIDO1ACHEKDM4E
SCHEMBL1103018 0.79 KDM4E (0.34) KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL1102773 0.76 ALOX5 (0.33)
SCHEMBL1102544 0.74 STAT3 (0.38) MAOAMAOBIDO1ACHEKDM4E
SCHEMBL1102506 0.74 ACHE (0.45) MAOAMAOBIDO1ACHEKDM4E
SCHEMBL1102517 0.74 ADRA2A (0.38) MAOAMAOBIDO1ACHEKDM4E
SCHEMBL1102505 0.74 HPGD (0.38) MAOAMAOBIDO1ACHEKDM4E
SCHEMBL1102734 0.74 P2RX4 (0.39) MAOAMAOBIDO1ACHEKDM4E
SCHEMBL1102546 0.73 MAOA (0.39) MAOAMAOBIDO1ACHEKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 MAOA 1588/4885MAOB 1209/4885IDO1 1871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.